{"DataElement":{"publicId":"3952852","version":"1","preferredName":"Thymoma Myasthenia Classification Category","preferredDefinition":"Extent of the thymoma tumor using the Myasthenia Classification system.","longName":"3952791v1.0:3952839v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3952791","version":"1","preferredName":"Thymoma Myasthenia Classification","preferredDefinition":"A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed)_A classification system for grading myasthenia gravis that divides the disease into 5 main classes and several subclasses.","longName":"3952785v1.0:3952789v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3952785","version":"1","preferredName":"Thymoma","preferredDefinition":"A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed)","longName":"C3411","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma","conceptCode":"C3411","definition":"A neoplasm arising from the epithelial cells of the thymus.  Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites.  The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma.  Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-804E-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3952789","version":"1","preferredName":"Myasthenia Classification System","preferredDefinition":"A classification system for grading myasthenia gravis that divides the disease into 5 main classes and several subclasses.","longName":"C112013","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Clinical Classification System","conceptCode":"C112013","definition":"A classification system developed by the Myasthenia Gravis Foundation of America (MGFA) for grading myasthenia gravis that divides the disease into 5 main classes and several subclasses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-80A2-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-80B3-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3952839","version":"1","preferredName":"Myasthenia Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"3952839v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Available","valueDescription":"Data Not Available","ValueMeaning":{"publicId":"2724564","version":"1","preferredName":"Data Not Available","longName":"2724564","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44539A54-AFEB-15E0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-81E4-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"Class I","valueDescription":"Myasthenia Class I","ValueMeaning":{"publicId":"3952840","version":"1","preferredName":"Myasthenia Class I","longName":"3952840","preferredDefinition":"Any ocular weakness. All other muscles strength is normal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Class I","conceptCode":"C112014","definition":"Myasthenia gravis presenting with any ocular weakness; may have weakness of eye closure. All other muscles strength is normal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-81F1-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-820A-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"Class II","valueDescription":"Myasthenia Class II","ValueMeaning":{"publicId":"3952841","version":"1","preferredName":"Myasthenia Class II","longName":"3952841","preferredDefinition":"Mild weakness affecting non-ocular muscles. May also have ocular muscle weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Class II","conceptCode":"C112015","definition":"Myasthenia gravis presenting with mild weakness affecting non-ocular muscles. May also have ocular muscle weakness of any severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8216-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-822F-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"Class III","valueDescription":"Myasthenia Class III","ValueMeaning":{"publicId":"3952842","version":"1","preferredName":"Myasthenia Class III","longName":"3952842","preferredDefinition":"Moderate weakness affecting non-ocular muscles. May also have ocular muscle weakness","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Class III","conceptCode":"C112016","definition":"Myasthenia gravis presenting with moderate weakness affecting non-ocular muscles. May also have ocular muscle weakness of any severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-823B-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-8254-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"Class IV","valueDescription":"Myasthenia Class IV","ValueMeaning":{"publicId":"3952843","version":"1","preferredName":"Myasthenia Class IV","longName":"3952843","preferredDefinition":"Severe weakness affecting non-ocular muscles. May also have ocular muscle weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Class IV","conceptCode":"C112017","definition":"Myasthenia gravis presenting with severe weakness affecting non-ocular muscles. May also have ocular muscle weakness of any severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8260-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-8279-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"},{"value":"Class V","valueDescription":"Myasthenia Class V","ValueMeaning":{"publicId":"3952844","version":"1","preferredName":"Myasthenia Class V","longName":"3952844","preferredDefinition":"Severe muscle weakness that requires intubation, with or without mechanical ventilation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis Foundation of America Class V","conceptCode":"C112018","definition":"Myasthenia gravis presenting with severe muscle weakness that requires intubation, with or without mechanical ventilation, except when employed during routine postoperative management.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-8285-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB3D0430-829E-BE47-E040-BB89AD431323","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3D0430-81C4-BE47-E040-BB89AD431323","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"COOPERM","dateModified":"2013-12-02","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Myasthenia Class","type":"Preferred Question Text","description":"Myasthenia Class","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3DA9F5-134E-7BEF-E040-BB89AD433FB2","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-15","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for Thymoma enrollment form per request by T.Lichtenberg. mc 11/15/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}